VRC 006 (04-I-0172)

A Phase I clinical Trial to Evaluate the Safety and Immunogenicity of a Recombinant Multiclade HIV-1 Adenoviral Vector Vaccine, VRC-HIVADV014-00-VP, in Uninfected Adult Volunteers.

Trial Details:

I Completed
National Institute of Allergy and Infectious Diseases (NIAID) July 19, 2004
VRC-HIVADV014-00-VP Ad5 env A, env B, env C, gag B, pol B
VRC-HIVADV014-00-VP Viral Vector - Adeno
USA 36